A Study Evaluating the Safety and Tolerability of GDC-0068 in Patients With Refractory Solid Tumors
Clinical trial NCT01090960 · COMPLETED
Trial details
- NCT number
- NCT01090960
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2015-02-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.